Dianthus Therapeutics (DNTH) has released an update to notify the public and investors about the unregistered sales of equity securities.
The disclosures provided in Item 1.01 are also included in this section as mandated by Form 8-K requirements.
For further insights into DNTH stock, check out TipRanks’ Stock Analysis page.